TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

American Assets Trust Inc (AAT)

Real Estate REIT - Diversified
23.60 $
-1.8% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at American Assets Trust Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 11 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
24.00$
Open
23.90$
Day High
24.10$
Day Low
23.40$
Volume
437,468shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
17.80 $ 25.90 $
01/28/2026 07/16/2026

Current price 23.60 $ — 72% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
1.8$B
Shares Outstanding
61Mio.
Float
78.5%
Beta
1.0

Performance

Perf. 1M
7.90%
Perf. 3M
38.70%
Perf. 6M
36.10%
YTD Performance (%)
32.80%
52-Week-High Distance
-1.1%
Perf. 1Y
32.41%
Perf. 3Y
26.21%
Perf. 5Y
-15.98%
Perf. 10Y
-22.27%
Perf. Since Inception
97.64%

Technical Indicators

MA 38 Days
24.70$
MA 50 Days
24.30$
MA 200 Days
20.50$
RSI (14)
37.3
Volatility 30 Days
21.0%
Volatility 250 Days
23.2%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
60.6
PEG
9.3
P/B
P/S
4.2
EV/EBITDA
13.1
Price/FCF
19.7

Profitability

Gross Margin
61.8%
EBIT Margin
Net Margin
4.1%
Return on Equity
2.2%
Return on Assets
2.1%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
Altman Z″
3.98
Piotroski
4 out of 9

Growth

Sales Growth Last Quarter
1.80%
EPS Growth Last Quarter
-88.00%
Sales Growth (Year)
-4.73%
Forward Sales Growth
2.94%
Forward EPS Growth

Dividend

Dividend Yield
5.77%
Dividend Per Share (TTM)
1.36$
Payout Ratio
1.9%
Years Without a Cut
5Years
Increase Streak
5Years

Quality & Screener

Stage
2
RS Rating
73
EPS Rating
4
Piotroski
4 out of 9
Fundamental Rating
D (32 out of 100)
Altman Z″
3.98

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

5 of 10 Solid growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 1.1% failed
  • More than 10% revenue growth is expected for the coming year 2.9% failed
  • Share count grows by less than 3% a year 0.2% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 17.0% failed
  • Gross margin at 40% or higher and without meaningful erosion 61.1% passed
  • Goodwill from acquisitions does not grow faster than revenue 0.0% passed
  • Net debt below twice EBITDA 5.7 x EBITDA failed
  • Operating cash flow covers the profits of the last three years 354 m passed
  • Return on capital at 15% or higher, or up versus two years ago 5.2% passed
  • Insiders hold at least 10% or are net buyers 1.8% failed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Analysts & Price Target

Current Price 23.60 $
Price Target (average) 23.50 $

The price target sits 0.4% below the current price.

Consensus
Hold
Analyst Ratings
3
Distribution of Recommendations
Strong Buy 0
Buy 0
Hold 3
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 0.39 0.39 – 0.39 444 1
12/31/2027 0.37 0.37 – 0.37 459 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

4. Aug 2026

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 113.5 $M Q4 2025: Q1 · 108.6 $M Q1 2025: Q2 · 107.9 $M Q2 2025: Q3 · 109.6 $M Q3 2025: Q4 · 110.1 $M Q4 2026: Q1 · 110.6 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.15 -14.40 114 0.90 10.20 41 22
2025: Q1 0.71 119.10 109 -1.90 49.80 37 20
2025: Q2 0.09 -63.40 108 -2.70 6.60 49 28
2025: Q3 0.08 -78.20 110 -10.80 5.40 41 23
2025: Q4 0.05 -63.70 110 -3.00 3.80 41 23
2026: Q1 0.07 -90.50 111 1.80 4.60 39 18
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 295 98 46 0.72 123 810 1,987
2017 315 94 40 0.63 146 844 2,260
2018 331 80 27 0.42 137 803 2,198
2019 367 114 60 1.11 154 1,294 2,790
2020 345 89 36 0.47 127 1,271 2,817
2021 376 100 37 0.48 168 1,210 3,018
2022 423 115 56 0.73 179 1,186 2,988
2023 441 122 65 0.85 189 1,154 2,985
2024 458 129 73 0.95 207 1,176 3,273
2025 436 146 71 0.93 167 1,151 2,921

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

American Assets Trust, Inc. ist ein Full-Service-, vertikal integrierter und eigenverwalteter Real Estate Investment Trust.

Employees232
HeadquartersSan Diego, CA
Address3420 Carmel Mountain Road, 92121-1069 San Diego, United States
Phone858 350 2600
Websiteamericanassetstrust.com
IPO Date13. Jan 2011
ISINUS0240131047

Management

Management
Name Title Birth Year
Ernest Sylvan Rady Executive Chairman of the Board 1937
Adam Wyll CEO, President & Secretary 1975
Robert F. Barton Executive VP, Treasurer & CFO 1957
Jerry Gammieri Senior Vice President of Construction & Development 1965
Christopher E. Sullivan Senior Vice President of Retail Properties 1962
Steve Center Senior Vice President of Office Properties
Meleana Leaverton Associate General Counsel

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?